Prostatis Group’s Pacer Trendpilot US Bond ETF PTBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-49,555
Closed -$49.6K – 193
2023
Q2
$49.6K Buy
+49,555
New +$992K 0.02% 179
2022
Q2
– Sell
-93,211
Closed -$2.27M – 72
2022
Q1
$2.27M Buy
93,211
+4,050
+5% +$104K 1.82% 21
2021
Q4
$2.4M Sell
89,161
-46,027
-34% -$1.24M 1.47% 23
2021
Q3
$3.67M Buy
135,188
+13,006
+11% +$360K 2.19% 13
2021
Q2
$3.39M Buy
122,182
+8,749
+8% +$241K 2.31% 12
2021
Q1
$3.09M Buy
+113,433
New +$3.11M 2.43% 11

Other funds holding PTBD

Prostatis Group's PTBD Position: Q3 2023 in Review

Prostatis Group sold out of Pacer Trendpilot US Bond ETF (PTBD) in Q3 2023, closing a stake of 49,555 shares — an estimated $49.6K sold.

Prostatis Group first reported a position in PTBD in Q1 2021 and held it in 6 quarters. The position peaked at $3.67M in Q3 2021. 61 funds tracked by Wall St. Rank hold PTBD as of Q3 2023.

  • Prostatis Group reported no remaining Pacer Trendpilot US Bond ETF position as of Q3 2023 after selling out during the quarter.
  • Prostatis Group sold 49,555 Pacer Trendpilot US Bond ETF shares in Q3 2023, an estimated $49.6K.
  • Prostatis Group first reported a position in Pacer Trendpilot US Bond ETF in Q1 2021 and held it in 6 quarters.
  • Prostatis Group's Pacer Trendpilot US Bond ETF position peaked at $3.67M in Q3 2021.
  • 61 funds tracked by Wall St. Rank held Pacer Trendpilot US Bond ETF as of Q3 2023.

Based on Prostatis Group's 13F filing for Q3 2023, filed 21 Mar 2025.